Back to StakeholdersPrimary Investment Link
Categories
1 domain / 2 areas / 1 specialization
Oppenheimer
Oppenheimer is tracked as an institutional-capital stakeholder relevant to financing exposure in psychedelic and adjacent mental-health sectors.
Investor Snapshot
Institutional InvestorsClassification
Institutional Investor
Geography
Global
Coverage
Global
Last Verified
Apr 17, 2026
Investment Stage Focus
Growth / Late StagePublic MarketsMulti-Stage
Investment Focus Areas
Drug Development
Investor Notes
Added from user-provided legacy investor list and retained with cross-tag-safe categorization. Explicit psychedelic relevance is captured from listed source evidence.
Verification
Unverified
Psychedelic Focus
No Public Psychedelic Focus
Engagement Status
Active
Source Evidence
Quick Facts
- Website
- Visit